[1] Abd TT, Eapen DJ, Bajpai A, Goyal A, Dollar A, Sperling L. The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Curr Atheroscler Rep 2011;13:154–161.

[2] Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279:48487–48490.

[3] Coe-Sullivan, Seth. Hybrid organic/quantum dot thin film structures and devices. PhD thesis, Massachusetts Institute of Technology, 2005.

[4] Harma H, Toivonen J. Time-resolved fluorescence immunoassay for C-reactive protein using colloidal semiconducting nanoparticles. Sensors 2011;11:11335–11342.

[5] I J. -W Park, S. Kurosawa, D. -S. Han, H. Aizawa, M. Yoshimoto, C. Nakamura, J. Miyake, S. -M. Chang. “Environmental immunosensor detection for 2,4- dinitrophenol as a model compound of dioxin”, I’rweedingv of (he 200 I IEFX lnlernational Frequency Control Symposium, pp.489-49 1, 2008.

[6] Islam MDS, Kang SH. Chemiluminescence detection of label-free C-reactive protein based on catalytic activity of gold nanoparticles. Talanta 2011;84:752–758.

[7] Kamat, Prashant V. Quantum Dot Solar Cells. Semiconductor Nanocrystals as Light Harvesters. The Journal of Physical Chemistry C 112 (December 2008): 18737-18753.

[8] Murphy, Catherine J. and Jeffery L. Coffer. Quantum Dots: A Primer. Appl Spectrosc. 2002;56, 16A-27A.

[9] Murray, Christopher B. Synthesis and Characterization of II-VI Quantum Dots and Their Assembly into 3D Quantum Dot Superlattices. PhD thesis, Massachusetts Institute of Technology, 1995.

[10]Pearson TA, Mensah GA, Hong Y, Smith SC Jr. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: overview. Circulation. 2004;110:e543- 544